Skip to main content
|

Add a bookmark to get started

Bookmarks info
ting xiao large

Ting Xiao

Partner
Regional Life Sciences Lead, Asia
Shanghai
About

Ting is a Partner in the IPT practice of DLA Piper's Shanghai office. She is also Regional Life Sciences Lead for Asia. Her practice focuses on patents, trade secrets and other technology-related matters. She specializes in licensing and technology transfer, life sciences and healthcare related regulatory work, and also handles IP enforcement and litigation matters.

Prior to her legal career, Ting worked as a research scientist in the National Key Laboratory of Chinese Academy of Sciences and a renowned research institute in Canada. Ting leverages her advanced scientific research background and deep understanding of client’s technical field to routinely advise clients from a wide variety of emerging and innovative sectors, including life sciences and healthcare, chemical, automotive, semi-conductor, information technology, artificial intelligence and new energy.

Areas of FocusLife SciencesIntellectual PropertyTechnology
Professional QualificationsAttorney-at-law admitted with the Supreme Court of New YorkBarrister and Solicitor registered with The Law Society of Upper Canada

EXPERIENCE

  • Representing one of the largest Chinese pharmaceutical CDMOs/CROs in multiple cross-border transactions, including an in-license of DNA library screening technology from a top U.S. university, a joint development and collaboration agreement with a U.S. supplier of API compounds, and multiple outbound service agreements.
  • Advising a large Vietnamese conglomerate on a complex technology and IP in-licensing, component supply and services transaction with a Chinese state-owned automobile manufacturer involving the Chinese automobile OEM’s electrical and electronic (E/E) architecture.
  • Advising a multinational pharmaceutical company in multiple non-contentious and contentious patent matters in China involving one of its blockbuster products, including patent ownership and trade secret dispute, pharmaceutical patent term extension, pharmaceutical patent linkage dispute and regulatory data exclusivity.
  • Acting for a large multinational network technology provider in the defense of patent infringement actions filed by patent trolls in China, including preparation of patent invalidation advice and filing and other related defense work in China.
  • Advising a major Chinese OEM of electronic devices in a court action brought by its licensor in U.S. concerning disputes on royalty payment and trademark infringement.
  • Advising multiple foreign companies on complex transaction to have its products “made in China” and distributed in China, including preparing manufacturing and IP license agreement, component supply agreement and advising on regulatory issues pertaining to such arrangement.
  • Advising pharmaceutical companies, drug packaging material companies, diagnostic healthcare products and medical device companies on various NMPA regulatory and compliance issues concerning market entry, advertising, product recall and inspection.
Languages
  • Chinese (Mandarin)
  • English
Education
  • University of Toronto, Juris Doctor
  • University of Toronto, Master of Science
  • Wuhan University, Bachelor of Science (Ranked 2nd out of 210)

Awards

  • “Leading Partner” for Life Sciences and Healthcare practice by Legal 500 Greater China 2025.
  • “Lawyer of the Year” for Life Sciences and Healthcare practice by The Legal 500 China Awards 2024.
  • Ranked in Chambers Greater China Region 2025, Life Sciences (International Firms).
  • “Patent Star” by Managing Intellectual Property 2023-2024.

My latest insights

Past event

What does your board need to know about the pharmaceutical landscape in China?

13 November 2024 .2 minute read

News

IP Stars recognizes 33 from DLA Piper's global IP practice in annual rankings

18 June 2024 .3 minute read

News

DLA Piper advises Calliditas Therapeutics in connection with Asahi Kasei’s US$1.1 billion...

4 June 2024 .2 minute read

View All

Connect

Phone

+86 21 3852 2111
(Work, Shanghai)
CallvCardLinkedInPrint
Privacy policyLegal noticesCookie policyModern slaveryWhistleblowingFraud AlertSitemap

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.

© 2025 DLA Piper